Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Warfarin in haemodialysis patients with atrial fibrillation: what benefit?Yang F; Chou D; Schweitzer P; Hanon SEuropace 2010[Dec]; 12 (12): 1666-72Warfarin is commonly used to prevent stroke in patients with atrial fibrillation; however, patients on haemodialysis may not derive the same benefit from warfarin as the general population. There are no randomized controlled studies in dialysis patients which demonstrate the efficacy of warfarin in preventing stroke. In fact, warfarin places the dialysis patient at increased risk for haemorrhagic stroke and possibly ischaemic stroke. Additionally, warfarin increases the risk of major bleeding and has been associated with vascular calcification. Routine use of warfarin in dialysis for stroke prevention should be discouraged, and therapy should only be reserved for dialysis patients at high risk for thrombo-embolic stroke and carefully monitored if implemented.|*Renal Dialysis[MESH]|Anticoagulants/adverse effects/therapeutic use[MESH]|Atrial Fibrillation/*complications[MESH]|Chronic Disease[MESH]|Hemorrhage/epidemiology[MESH]|Humans[MESH]|Kidney Diseases/therapy[MESH]|Risk Factors[MESH]|Stroke/epidemiology/*prevention & control[MESH]|Warfarin/adverse effects/*therapeutic use[MESH] |